
Adult Immunization
Latest News

FDA Identifies NDA Deficiencies for Anaphylm as Review Continues, Aquestive Therapeutics Announces

Investigational Oral PCSK9 Inhibitor Matches Injectable Efficacy in Patients with HeFH: Daily Dose

Implementation Gaps Persist in Guideline-Recommended UACR Management in Primary Care: A Conversation with Holly Kramer, MD

Updated Dietary Guidelines Emphasize Protein, Full-Fat Dairy, and Limits on Ultra-Processed Foods

FDA Green Lights First At-Home Brain-Stimulation Device for MDD: Daily Dose
Shorts










Latest Videos
Podcasts
Screening
All News

Your daily dose of the clinical news you may have missed.

A nephrology expert discusses survey findings that reveal gaps between UACR testing and action in cardiovascular risk assessment for type 2 diabetes.

COVID-19 vaccination before infection significantly reduces hospitalization, critical care admissions, and preterm birth rates in pregnant individuals, study finds.

Your daily dose of the clinical news you may have missed.

Long-acting HIV prevention options simplify adherence, reduce stigma, and empower individuals to maintain their health without daily reminders.

FDA prioritizes review of Tzield for young children with stage 2 type 1 diabetes, potentially delaying disease onset and improving patient outcomes.

Your daily dose of the clinical news you may have missed.

The FDA has accepted a supplemental NDA for AXS-05 for agitation associated with Alzheimer disease and granted Priority Review, with a PDUFA action date of April 30, 2026.

Take a quick look back at developments this year with our higlights of acceleration of DMTs, particularly focusing on anti-amyloid antibodies and novel oral agents.





































































































































































































































































































































